Immunological memory to SARS-CoV-2 assessed for greater than six months after infection (biorxiv.org)

The memory component of the immune response to SARS CoV-2 is coming into focus. It appears to be a bit heterogenous, much like the initial response, but “immune memory consisting of at least three immunological compartments was measurable in ~90% of subjects > 5 months PSO, indicating that durable immunity against COVID-19 disease is a possibility in most individuals.”

Singapore biotech firm hopes for ‘widespread’ release of new Covid-19 treatment by early 2021 (cnbc.com)

We might find ourselves awash with vaccines and treatments for COVID-19 in early 2021. It’s possible that in the span of a year, the clinical challenge may have gone from not knowing how to treat the disease at all to not know which treatment is the best to use in a particular situation.